The SLC22 transporter family, a member of the major facilitator superfamily MFS, comprises polyspecific transporters with twelve presumed transmembrane α-helices (TMH) for organic cations, organic anions and zwitterions Koepsell, 2004) . Three subtypes of polyspecific organic cation transporters have been identified (SLC22A1-3 or OCT1-3). These transporters are critically involved in the elimination of cationic drugs and metabolic waste products in liver and kidney. OCT1 is mainly expressed in liver where it is localized at the sinusoidal membrane of the hepatocytes Gorboulev et al., 1997; Meyer-Wentrup et al., 1998) . It mediates the first step in biliary secretion of organic cations, i.e. their uptake into hepatocytes. Because the transporters OCT1-3 can transport cations in both directions (Busch et al., 1996; Budiman et al., 2000; Koepsell et al., 2003) OCT1 is supposed to be also responsible for the release of organic cations across the sinusoidal membrane into the blood. Employing nontransported inhibitors in combination with giant patch method we determined ligand affinities of the outwardly and inwardly oriented conformations of the substrate binding region of rat OCT2 (Volk et al., 2003) . These data suggest that the binding region of rOCT2 comprises overlapping binding sites for different substrates which differentially alter their affinity during reorientation. This interpretation was supported by the observation that the mutation of aspartate 475 to glutamate in the binding region of rOCT1 led to a drastic increase in affinity for some substrates and competitive inhibitors, but did not influence the affinity of another substrate .
For the understanding of drug transport and for the design of drugs with optimized biodistribution and excretion, it is important to elucidate the structure of the substrate binding regions of polyspecific transporters of the SLC22 family, how various substrates bind to these regions, whether more than one substrate can bind simultaneously, and how substrate binding initiates the translocation process. Ultimately, these questions can only MOLPHARM/2004/008839 5 be solved by crystallization of ligand-transporter complexes in combination with functional characterization of point mutations of critical residues.
In recent years, functional effects of many individual point mutations on transport activity and/or substrate affinity of transporters of the SLC22 family have been described (Koepsell and Endou 2004; Koepsell et al., 2003) . It turned out that mutations in several of the presumed twelve membrane-spanning α-helices (TMHs 1, 2, 4, 7, 8, 11) , in the large extracellular loop, and in the large intracellular loop lead to functional changes such as differential affinity changes for various substrates. Considering the possibility that part of these changes may be due to long-range effects on the conformation of the substrate binding region, we reasoned that indirect effects were much less probable if amino acids with specific effects on substrate affinity could be identified in neighbouring positions within the secondary structure, e.g. on one side of an α-helix. For this reason, we carried out a systematic mutational screening of the presumed 4 th TMH of rOCT1. We measured transport activity for two different substrates in mutants of 18 consecutive amino acids and investigated 9 of these amino acids in more detail. The 4 th TMH was selected because this TMH contains several amino acids on one side of the presumed α-helix that are conserved within the three OCT-subtypes but not in the closely related organic anion transporters. We obtained data indicating that 3 amino acids in neighbouring positions on one side of the presumed 4 th TMH participate in substrate binding.
Recently, the three-dimensional structures of three members of the major facilitator superfamily, the oxalate transporter OxlT from Oxalobacter formigenes (Hirai et al., 2002) , the lactose permease LacY Escherichia coli (Abramson et al., 2003) , and the glycerol-3-phosphate transporter GlpT from Escherichia coli (Huang et al., 2003) have been reported. These transporters had similar structures containing large clefts that were crystallized in an orientation directed to the cytosol. For LacY it was shown that this cleft contained the substrate binding site. On the basis of the structure of LacY we modelled the 
Experimental Procedures
Site-Directed Mutagenesis. Point mutations were introduced in rOCT1 by polymerase chain reaction (PCR) applying the overlap extension method (Ho et al., 1989) . The oligonucletides used as flanking primers were: 5´CCA TCT ATG TGG GCA TCG3´ (rOCT1, nucleotides 138-155) and 5´ACA GCA GGA AGA GGA AGG3´ (rOCT1, nucleotides 872-855). The PCR amplificates were digested with AccI and NheI and gel-purified fragments were ligated into wild-type rOCT1/pRSSP vector (Busch et al., 1996) that was cut with the same restriction endonucleases. The fragments introduced into rOCT1/pRSSP were sequenced to confirm the presence of the desired mutations and to exclude PCR errors. For immunodetection, the FLAG epitope (DYKDDDDK) was added to the C-terminus of rOCT1 wild-type and mutants, employing the overlap extension PCR procedure and using the rOCT1-FLAG primers (with underlined FLAG sequence) 5´GAC TAC AAG GAT GAC GAT GAC AAG TGA CAG GGA TGC TG3´ (forward) and 5´CTT GTC ATC GTC ATC CTT GTA GTC AGT ACT TGA GGA CTT G3´ (reverse). The PCR amplificates were digested with Eco130I and BglII, gel-purified and substituted for the respective fragment of rOCT1 in the rOCT1/pRSSP vector.
cRNA Transcription and Expression in Xenopus Oocytes. For injection into
Xenopus oocytes, m7G(5´)ppp(5´)G-capped sense cRNAs were transcribed in vitro using the "mMESSAGE mMACHINE" kit (Ambion, Cambridgeshire, UK). The pRSSP vectors MOLPHARM/2004/008839 7 containing rOCT1 wild-type or rOCT1 mutants (Busch et al., 1996) were linearized with MluI, and cRNAs were synthesized using SP6 RNA polymerase. cRNA concentrations were estimated from ethidium bromide-stained agarose gels using polynucleotide marker as standards . Stage V-VI oocytes were defolliculated with collagenase A (Veyhl et al., 1993) and stored for several hours in Ori buffer [5 mM 3-(N-morpholino)propanesulfonic acid-NaOH, pH 7.4, 100 mM NaCl, 3 mM KCl, 2 mM CaCl 2 , and 1 mM MgCl 2 ] supplemented with 50 mg/l gentamicin. The oocytes were injected with 10 ng of the respective cRNA in 50 nl H 2 O. For comparison in parallel experiments, cRNAs of wild-type and mutant rOCT1 were injected within 3 h into oocytes from the same batch. For transporter expression, the oocytes were incubated for 3-5 days at 16 o C in Ori buffer supplemented with 50 mg/l gentamicin.
Enrichment of Plasma Membranes of Xenopus
Oocytes. -Three days after incubation of cRNA-injected oocytes or noninjected oocytes in Ori buffer, a plasma membrane-enriched fraction was prepared at 4 o C as described (Geering et al., 1989) .
Oocytes were homogenized in homogenization buffer (10 mM HEPES pH 7.9, 83 mM NaCl, 1 mM MgCl 2 , 1 mM PMSF, 0.05 ng/ml leupeptin, 10 mM benzamidine), centrifuged for 10 min at 1,000xg and the supernatant was carefully removed leaving lipids behind. The pellet was suspended in homogenization buffer, centrifuged for 10 min at 1,000xg and the supernatant was collected. Both supernatants were combined and centrifuged for 20 min at 10,000xg. The pellet was suspended in homogenization buffer and re-centrifuged for 20 min at 10,000xg. The obtained pellet is enriched in plasma membranes as previously demonstrated by marker enzymes (Geering et al., 1989) and by immunodetection of the expressed Na + -D-glucose cotransporter SGLT1 (Valentin et al., 2000) . Protein was quantified according to Bradford using bovine serum albumin as standard (Bradford, 1976 (Valentin et al., 2000) . Proteins were transferred to polyvinyldifluoride membrane and incubated with affinity purified polyclonal antibody raised against the large extracellular loop of rOCT1 as described earlier (Meyer-Wentrup et al., 1998 Germany) was used to determine apparent molecular masses.
Immunocytochemistry. Oocytes were treated as described (Wolff et al., 2001 (Fig. 4) or (ii) to compare K M or V max between different mutants from measurements that were not strictly performed in parallel (Fig.4) . In the experimental series shown in Fig. 3 we performed analysis of ANOVA followed by Tukey´s test to assess the differences between relative uptake rates of five different substrates by various mutants.
Modelling the Tertiary Structure of rOCT1. We used the tertiary structure of lactose permease LacY from E. coli which was recently crystallized (pdb entry 1PV6, Abramson et al., 2003) , to model the tertiary structure of the putative transmembrane α-helices (TMHs) of rOCT1. The putative TMHs of rOCT1 indicated in Fig. 6 were predicted using the software TMHMM (http://www.cbs.dtu.dk/services/TMHMM/). The putative TMHs of rOCT1 were then aligned to the respective helices of LacY using CLUSTALW or Bestfit of the software package GCG Wisconsin (Accelrys). The model was built by replacing the residues of LacY with the corresponding residues of rOCT1 using the software package Quanta2000 (Accelrys). Close contacts were removed by rotamer searches for the affected side chains. Further steric clashes were eliminated employing energy minimization procedures utilizing the CHARMM forcefield (Accelrys). The backbone geometry was retained by defining distance restraints for the backbone atoms mimicking the hydrogen bonding pattern of LacY. These distance restraints obeyed an NOE-like constraints potential with upper and lower distance boundaries; target distance was set to 2.1Å, lower boundary was set to 1.9Å between the amide proton and the carbonyl oxygen, upper boundary for this atom pair was set to 2.4Å. At sites where non-glycine or non-prolines residues of the LacY template were exchanged to glycine or prolines of rOCT1, no distance restraints were used to allow for an adaptation of the backbone conformation. The distances were weighted with a rather high force constant of 250 kcal mol -1 Å -2 in the initial refinement steps (first 100 minimization steps) and the force constant was then gradually lowered (100 minimization steps per round, lowering the force constant by 50 kcal mol -1 Å -2 each round, final force constant 50 kcal mol -1 Å -2 ) to allow for more conformational freedom during the final steps of energy minimization within CHARMM.
The overall fold was maintained also by a set of distance restraints that were defined between the N-and C-terminal "ends" of the TMHs. These distance were also used with upper and lower boundaries, however the boundaries were set to ±25% of the respective distance to allow for smaller changes in the packing of the TMHs. After several rounds of energy minimization a short molecular dynamic simulation in vacuo (10 ps) was performed with the backbone and overall geometry restrained as indicated above using the CHARM forcefield of the software package QUANTA2000. These maneuvers led to low energies for geometry and van der Waals interaction terms. The large loops of rOCT1 were excluded from the modelling since LacY lacks a corresponding structure (loop between TMH 1 and 2) or exhibits low structural similarity (loop between TMH 6 and 7). TBq/mmol) were purchased from Amersham Bioscience Europe GmbH (Freiburg, Germany), and tetrapentylammonium (TPeA) from Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany). The other chemicals were obtained as described earlier (Arndt et al., 2001; Meyer-Wentrup et al., 1998) .
Materials

Results
Mutation Scanning of Amino Acids Comprising the Presumed 4 th Transmembrane
α-Helix of rOCT1. To investigate the role of the presumed 4 th transmembrane α-helix (TMH) for cation selectivity of rOCT1 we replaced each amino acid between positions 212-229 with similar amino acids or with amino acids from corresponding positions in other members of the SLC22 transporter family was replaced by alanine, a less bulky amino acid than leucine, relatively high uptake rates of TEA (32% of wild-type) and MPP (54% of wild-type) were expressed.
To investigate translation and membrane insertion for mutants that did not express uptake of TEA (K215R, E227D, V229L), we performed Western blots with enriched plasma membranes and investigated the localization of the transporters in intact oocytes.
To enable the immunocytochemical detection in acrylamide-embedded oocytes, we appended a FLAG-tag to the C-terminus of wild-type and mutant transporters. With FLAG-tagged wild-type rOCT1, a similar uptake rate of 10 µM [ 14 C] TEA was expressed compared to non-modified wild-type. No significant uptake of TEA was expressed with the FLAG-tagged mutants K215R, E227D and V229L as observed with the unmodified mutants (data not shown). Western blots with preparations of enriched plasma membranes obtained by differential centrifugation revealed similar staining for FLAG-tagged wildtype and mutants. The Western blot in Fig.1a was developed with a previously described affinity-purified antibody against the large extracellular loop of rOCT1 (Meyer-Wentrup et al., 1998) . The antibody reacted with two polypeptide bands with apparent molecular masses of ~ 50 and ~ 70 kDa and showed a less intense reaction with a ~ 45 kDa protein.
The intensity of this band varied between different experiments .
The upper band was absent after deglycosylation (unpublished data). Together, these data indicate that the mutants are translated and glycosylated similar to rOCT1 wild-type. Fig. 1b shows immunostaining of oocytes expressing FLAG-tagged wild-type and FLAG-tagged mutants K215R, E227D and V229L using a monoclonal antibody against the FLAG epitope. Immunostaining at the plasma membrane in oocytes expressing rOCT1
wild-type and the mutants indicates translation and membrane insertion. By fluorescence microscopy and confocal laser scanning microscopy we were not able to differentiate staining at the plasma membrane from vesicles just beneath it (data not shown). For this reason and because the FLAG-tag was attached to the intracellular C-termini, the immunolocalization data do not exclude location in vesicles beneath the plasma membrane.
After replacing G216 by alanine, W218 by phenylalanine, S220 by isoleucine, or T226 by alanine, the uptake of 10 µM TEA was reduced to a greater extent than the uptake of 0. for MPP were significantly decreased whereas the K M and V max for TEA showed only a trend for a decrease. Since also this mutation lead to an affinity increase it was further characterized (see below). Finally, in the V229A mutant, the K M for TEA was significantly increased vs. wild-type whereas the K M for MPP was not changed significantly.
Further Characterization of Mutants of Conserved Amino Acids Localized on
one Side of the Presumed 4 th TMH. Secondary structure prediction suggests a TMH between amino acids 212 and 229 ). An α-helical wheel representation of that TMH shows that the two mutations with significantly increased substrate affinity (Y222F, T226A) affect amino acids on the same side of this α-helix (Fig.   2) . They belong to a group of five neighbouring amino acids on this side of the presumed 4 th TMH (K215, W218, Y222, T226, V229) that are conserved in organic cation transporters but not in organic anion transporters (Arndt et al., 2001; Koepsell et al., 2003) ; therefore, changes in the uptake rates may reflect changes in affinity, maximal transport velocity, or both.
Mutants K215Q, K215R, and V229L which did not mediate uptake of TEA and MPP (see Table 1 ) were also not able to mediate uptake of guanidine, histamine or serotonin (data not shown). With mutant V229A, uptake rates for TEA, MPP, guanidine, histamine, and serotonin were about 50% of the respective uptake rates observed with rOCT1 wildtype. The substrate selectivity of this mutant was not different from wild-type (data not shown). Mutants W218F, W218Y and W218L exhibit significantly different substrate selectivities between each other and compared to rOCT1 wild-type (Fig. 3) . In all three W218 mutants, the smallest changes of uptake rates compared to wild-type were observed for MPP. In W218F and W218Y, the uptake rates for MPP were similar to wild-type, but reduced by about 80% in W218L. Significant changes in substrate selectivity were also observed after mutations of Y222 and T226 (Fig. 3) . Substrate selectivity was changed in mutant Y222L but not in Y222F. A unique substrate selectivity different from wild-type was also obtained in the T226A mutant.
When changes in substrate selectivity are identified by uptake measurements of different substrates using a single fixed concentration of each substrate as in Fig. 3 , changes in affinity cannot be distinguished from changes of maximal transport rate.
Changes in K M may thus be overlooked if they are combined with opposite changes of V max . For example, after replacement of Y222 by phenylalanine, the uptake rates of 10 µM TEA and 0.5 µM MPP were similar to wild-type (Fig. 3) although the K M and V max values for TEA were significantly decreased compared to wild-type (Table 2) . When the affinity of a substrate is increased after a point mutation, we reasoned that the respective amino acid may be involved in substrate binding because it is not very likely that an increase of affinity is caused by an indirect effect on the structure. It is obvious that point mutations in a substrate binding site can lead to a decrease in substrate affinity, however, there is a high probability that mutations outside a binding site induce structural changes that have the same effect.
A significant decrease of the K M for TEA was observed in mutant Y222F, and a significant decrease of the K M for MPP in mutant T226A (Table 2) . Thus, Y222 and T226
are probably localized in the substrate binding region of rOCT1. To understand the functional role of W218 which is localized next to Y222 on the α-helix, and to further investigate the functional role of Y222, we compared substrate dependence of TEA uptake vs. MPP uptake after replacement of W218 by phenylalanine, tyrosine and leucine, and after replacement of Y222 by phenylalanine and leucine. Fig. 4 shows the apparent K M and V max values of these mutants. As described above, the K M values for TEA and MPP and the V MAX for MPP were not changed by the W218F mutation whereas the V max for TEA uptake was decreased by 50% (Table 2 and Fig. 4 ). When W218 was replaced by tyrosine, the function of rOCT1 was changed in a different way: K M and V max values for both, TEA and MPP, were decreased significantly compared to wild-type. Note, that the additional hydroxyl group in W218Y compared to W218F leads to a higher affinity for both, MPP and TEA. Replacement of W218 by leucine resulted in a drastic decrease of the affinity for TEA whereas the affinity for MPP was not changed. At variance, after the exchange of this amino acid, the V max values for TEA and MPP uptake were decreased by similar degrees.
In summary, point mutations in position 218 can lead to changes in substrate affinity and transport rates that are independent from each other. The changes in substrate affinity can be specific for certain substrates and can include an increase of substrate affinity. The data suggest that in addition to Y222 and T226, also W218 is localized within the substrate binding region of rOCT1 and that W218 can interact with both TEA and MPP. The K M independent changes of V max observed in mutants W218F and W218L suggest that W218
participates in conformational changes during substrate translocation.
Different effects on the affinity of TEA and MPP were also observed when Y222 was replaced by phenylalanine or leucine. As described above, the K M for TEA uptake in Y222F was significantly decreased, whereas the K M for MPP uptake remained unchanged suggesting that Y222 is located in the substrate binding region (Table 2 , Fig.4 ). When Y222 was replaced by leucine, the K M for TEA and MPP decreased by similar degrees (Fig. 4 , TEA by 53%, MPP by 65%). In parallel, the V MAX values for TEA and MPP were decreased by 91 and 90%, respectively. The functional properties of Y222L support the interpretation that Y222 is localized in the substrate region of rOCT1.
To further characterize mutants Y222F and Y222L we investigated the effect of these mutations on two high affinity inhibitors, cyanine863, and the quaternary ammonium salt tetrapentylammonium (TPeA). Previous mutagenesis showed that TPeA binds to the substrate binding region of rOCT1 . In the Y222F mutant, the IC 50 value for inhibition of TEA (10 µM) uptake by cyanine863 was not significantly different from rOCT1 wild-type (data not shown). However, the IC 50 value for inhibition of TEA uptake by TPeA was largely decreased (Fig. 5) (Gorboulev et al., 2005) ), and one amino acid in the 11 th TMD (D475, Gorboulev et al., 1999) were assigned to the substrate binding region of rOCT1. Fig. 6 shows an alignment of the presumed TMHs of the three OCT subtypes from rat and human with the respective helices of the LacY. For the sequences shown in Fig. 6, 12 .4% of the amino acids were identical between rOCT1 and LacY whereas 28.8% of the amino acids were similar. Considering the sequences of the three OCT subtypes from human and rat together, 18.5% of amino acids were identical and 37% of the amino acids were similar between at least one of the OCTs and LacY. By analogy to the tertiary structure of LacY (Abramson et al., 2003) and two other transporters of the MFS superfamily, the oxalate transporter OxlT from Oxalalobacter formigenes (Hirai et al., 2002) and the glycerol-3-phosphate transporter GlpT from E. coli. (Huang et al., 2003) , the model in Fig. 7 shows a large cleft in rOCT1 that is accessible from the intracellular side of the membrane. (Fig. 7a) . The model is strongly supported by our mutagenesis experiments because all amino acids that have been identified to be involved in the substrate binding (4 th TMH W218, Y222 and T226, 10 th TMH A443, L447 and Q448, 11 th TMH D475) are located in the large cleft of the modelled transporter and are accessible from the aqueous phase ( Fig.7a-c Since similar high resolution tertiary structures have been reported for LacY and GlpT (Abramson et al., 2003; Huang et al., 2003) and the amino acid similarity between these transporters is not larger than the similarity between rOCT1 and LacY, it is likely that the tertiary structure of rOCT1 is similar to both proteins. A comparison between the MOLPHARM/2004/008839 20 structures of LacY and GlpT showed that the transmembrane topology is highly conserved between these two transporters, a structural alignment yields a root mean square deviation of 4Å if the Cα atoms of 382 equivalent residues are considered (PDB entry 1PW4 was used for GlpT, PDB entry 1PV6 was used for LacY). Comparing the structural model of rOCT1 with to tertiary structure of GlpT, the Cα atoms of the seven residues within the substrate binding region of rOCT1 are within a distance of less than 4Å compared to the respective residues of GlpT and exhibit similar side chain orientations.
Discussion
The mutagenesis experiments presented in this paper strongly suggest that the three amino acids W218, Y222, and T226 on succeeding turns of the presumed 4 th TMH form part of the substrate binding region of rOCT1. Mutations in these amino acids resulted in significant decreases of K M values for MPP and/or TEA. In mutants W218Y and Y222L
the K M values were decreased for both TEA and MPP, in mutant Y222F the K M value for TEA was decreased, and in mutant T226 the K M value for MPP was decreased. The data suggest that TEA and MPP bind to W218 and Y222 and that MPP binds also to T226.
Ionic interaction of the positive charges in TEA and MPP with π-electrons of W218 and Y222 (Dougherty, 1996) as well as hydrophobic and van der Waals interactions with W218, Y222 and T226 may be involved. W218 is supposed to play a role in TEA translocation because in the W218F mutant the V max value for TEA was decreased whereas the K M for TEA remained unchanged. Y222 may be important for the translocation of MPP since in the Y222F mutant the V max value for MPP was decreased whereas the K M for MPP was not altered.
Mutation of other amino acids in the presumed 4 th TMH drastically decreased transport activity (K215Q, K215R, E227Q, E227D, V229L, see Table 1 ) or increased K M value for TEA and changed substrate selectivity (V213G, V229A, see Table 2 ). These amino acids may be crucial for the tertiary structure of the substrate binding region. In mutant V213G, the K M values for TEA and MPP were increased by different degrees, and in mutant V229A, the K M value for TEA was increased whereas the K M value for MPP was not changed. V213 is localized on the opposite side of the presumed 4 th TMH compared to W218, Y222 and T226 (see Fig. 2 ). Its replacement by alanine may change the position of the 4 th TMH and thus the position of W218, Y222 and T226 (see model in Fig. 7a,c) . V229
on the same side of the 4 th TMH as W218, Y222 and T226 (Fig. 2) is located close to the transition between the 4 th and 5 th TMH (Fig 7c) . After replacement of V229 by leucine, this more bulky amino acid compared to valine or alanine may interact with the 5 th TMH and thereby change the position of 4 th TMH that contains the above described substrate binding domain.
The crystal structure of the lactose permease LacY from E. coli (Abramson et al., 2003) provided the possibility to model the tertiary structure of the TMHs of rOCT1. rOCT1
belongs to the same MFS superfamily of transporters as LacY , and shows 29% similar amino acids in the TMHs. We tested the validity of the structural rOCT1 model by evaluating the localization of seven amino acids that have been shown to be involved in substrate binding by mutagenesis experiments. Three amino acids on the presumed 4 th TMH (W218, Y222, T226) were identified above, three amino acids on the presumed 10 th TMH (A443, L447, Q448) were identified in the accompanying paper (Gorboulev et al., 2005) , and one amino acid in the 11 th TMH (D475) was identified earlier . All seven amino acids fulfill the criterium that their exchange with an appropriate amino acid lead to an increase of substrate affinity that was often combined with a change in substrate selectivity. Such a change of function is not likely to be induced by indirect effects. For W218, Y222 and T226, indirect effects can be virtually excluded as reason for the observed affinity changes in all three positions. The high quality of our model of rOCT1 is strongly supported by the finding that all seven amino acids, which belong to the substrate binding region as judged from mutagenesis, are located within one structural epitope in the large cleft of the rOCT1 model and are in contact with the aqueous phase.
The positions of the seven amino acids in the modelled cleft of rOCT1 suggests that two or more substrates can bind in parallel to this conformation of the transporter. A decrease of the K M value for TEA was observed after mutations of D475 in the 11 th TMH , of W218 or Y222 on successive turns of the 4 th TMH, and after a combined mutation of A443, L447 and Q448 in the 10 th TMH (Gorboulev et al., 2005) , and in our model one TEA molecule cannot interact simultaneously with D475, W218, Y222, and an amino acid in the 10 th TMH. Our mutagenesis experiments indicate that the binding sites for TEA in the proposed substrate binding region overlap with the binding sites for MPP, TPeA and/or corticosterone. Note that in addition to TEA (i) the affinity for MPP was increased in mutants of W218, of Y222 and in the triple mutant A443/L447/Q448, (ii) the affinity of corticosterone was increased after mutations of A443, L447 and /or Q448, and (iii) the affinity for TPeA was increased after mutations of D475 and Y222 (see above, Gorboulev et al., 1999, and Gorboulev et al., 2005) .
Our interpretation that two or more substrates and/or inhibitors can bind at the same time is supported by data that suggest short-range allosteric interactions between ligands within the substrate binding region of rOCT1 (Gorboulev et al., 2005) . After exchanging two amino acids in the substrate binding region (L447Y/Q448E) we observed a significantly higher affinity for inhibition of TEA (10 µM) uptake by corticosterone compared to the inhibition of MPP (0.1 µM) uptake by corticosterone. These data suggest different short-range allosteric interactions between TEA and corticosterone vs. MPP and corticosterone because (i) TEA, MPP and corticosterone bind to the substrate binding region, (ii) the differences in corticosterone affinity cannot be explained with different replacement of corticosterone by the two substrates, and (iii) it is unlikely that the observed substrate effect on corticosterone affinity is due to allosteric interaction between rOCT1 monomers because it was only observed after mutation of two amino acids in the substrate binding region.
The question arises whether simultaneous binding of more than one substrate molecule to the substrate binding region of rOCT1 is compatible with the observations (i) that rOCT1 exhibits Michaelis-Menten type kinetics , ( The proposed hypothesis that rOCT1 contains a large substrate binding region within a large cleft that can bind simultaneously several substrates and/or inhibitors is consistent with the crystal structure of the multidrug efflux pump AcrB from E. coli (Yu et al., 2003) .
AcrB is a polyspecific transporter like rOCT1, however, it has no structurally similarity to rOCT1 and is energized by a proton-gradient. Interestingly, crystal structures of AcrBligand complexes showed, (i) that three ligands bind simultaneously to a binding region of AcrB, (ii) that different ligands use a slightly different subset of AcrB residues for binding, and (iii) that the bound ligands interact with each other. At variance to AcrB which contains a channel-like transmembrane path, the proposed LacY-like structure of rOCT1
implicates and functional data suggest that the large cleft in rOCT1 may be accessible either from the intracellular side of the plasma membrane or from the extracellular side of the plasma membrane (Volk et al., 2003) . It is a challenge to determine the crystal structure of rOCT1 and resolve the transport mechanism.
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